Xyotax Retains Fast Track Status For Certain Female Lung Cancer Patients
This article was originally published in The Pink Sheet Daily
Executive Summary
Trials of Xyotax in women with lung cancer who have normal estrogen levels are landmark studies using estrogen as a biomarker, CTI says.